Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk Factors and Outcomes Associated with Isolation of Meropenem High-Level-Resistant Pseudomonas aeruginosa

7 Jul 2009

Abstract excerpt

OBJECTIVE: To determine risk factors and outcomes for patients with meropenem high-level-resistant Pseudomonas aeruginosa (MRPA) (minimum inhibitory concentration [MIC] > or = 32 microg/mL). DESIGN: Case-control-control. SETTING: An 867-bed urban, teaching hospital. PATIENTS: Fifty-eight MRPA case patients identified from an earlier P. aeruginosa study; 125 randomly selected control patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Antibiotics Pharmacokinetics and Efficacy
Share to Nosocomial Infections in ICU

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 19583513
DOI: 10.1086/603527

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk Factors and Outcomes Associated with Isolation of Meropenem High-Level-Resistant Pseudomonas aeruginosaPMID 19583513Read ↗

Clinical and microbiological features of infections caused by Pseudomonas aeruginosa in patients hospitalized in intensive care units.Semantic proximity Read ↗

A large sustained endemic outbreak of multiresistant Pseudomonas aeruginosa: a new epidemiological scenario for nosocomial acquisition.Semantic proximity Read ↗

Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes.Semantic proximity Read ↗

Risk Factors for Acquisition of Multidrug-Resistant Pseudomonas aeruginosa Producing SPM Metallo-β-LactamaseSemantic proximity Read ↗

Acquisition of Pseudomonas aeruginosa and its resistance phenotypes in critically ill medical patients: role of colonization pressure and antibiotic exposure.Semantic proximity Read ↗

Risk factors for mortality in pseudomonas aeruginosa bacteremia in childrenSemantic proximity Read ↗

Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002.Semantic proximity Read ↗

Antibiotic exposure and resistance development in Pseudomonas aeruginosa and Enterobacter species in intensive care units.Semantic proximity Read ↗

Extensively drug-resistant Pseudomonas aeruginosa: risk of bloodstream infection in hospitalized patients.Semantic proximity Read ↗

Influence of Multidrug Resistance and Appropriate Empirical Therapy on the 30-Day Mortality Rate of Pseudomonas aeruginosa BacteremiaSemantic proximity Read ↗

Outcomes of Bacteremia due to Pseudomonas aeruginosa with Reduced Susceptibility to Piperacillin-Tazobactam: Implications on the Appropriateness of the Resistance BreakpointSemantic proximity Read ↗

Impact of meropenem exposure on fluoroquinolone and carbapenem resistance in Pseudomonas aeruginosa infection in inpatients in a Japanese university hospital: Insights into oprD mutations and efflux pump overexpression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.